氟哌噻吨美利曲辛联合莫沙必利、泮托拉唑在功能性 消化不良治疗中的应用效果

薛海荣 1 ，李婉妮 2

1.西安一四一医院，陕西 西安，710089；2.宝鸡文理学院医院内科，陕西 宝鸡，721013

浏览次数：155次 下载次数：401次

摘要：

目的 探讨氟哌噻吨美利曲辛联合莫沙必利、泮托拉唑在功能性消化不良（FD）治疗中的应用效果。方法 以我院收治的108例 FD 患者为研究对象，根据随机数字表法将患者分为对照组和研究组，各 54例。对照组联合应用莫沙必利与泮托拉唑治疗，研究组在对照组基础上联合氟哌噻吨美利曲辛治疗。比较两组患者的临床疗效、治疗前后临床症状评分及不良反应发生率。结果 研究组的治疗总有效率高于对照组（p＜0.05）。治疗后，两组的餐后饱胀、早饱感、上腹疼痛或不适、上腹烧灼感评分均较治疗前明显降低，且研究组显著优于对照组（p＜0.05）。两组的不良反应发生率无显著差异（p＞0.05）。结论 氟哌噻吨美利曲辛联合莫沙必利、泮托拉唑可有效改善 FD 患者的临床症状，疗效显著，且不增加不良反应，值得临床推广。

关键词： 氟哌噻吨美利曲辛；莫沙必利；泮托拉唑；功能性消化不良

中图分类号： R57文献标志码：A文章编号：2096-1413(2018)07-0020-02

Application effect of flupentixol and melitracen combined with mosapride and
pantoprazole in the treatment of functional dyspepsia


XUE Hai-rong 1 ,LIW an-ni 2*
(1.Xi`an 141 Hospital,Xi`an 710089;2.Internal Medicine Department,the Hospital of Baoji University of Artsand
Sciences,Baoji 721013,China)



ABSTRACT: Objective To explore application effectofflupentixoland melitracen combined with mosaprideand pantopra-zolein the treatment of functional dyspepsia(FD). Methods The clinical data of 108 patients with FD in our hospital were studied,the patients were divided into control group and study group according to the random number table,with 54 cases in each group. The control group was treated with mosapride and pantoprazole.The study group was treated with flupentixol and melitracen on the basis of the control group.The clinical efficacy,clinical symptom scores before and after treatment and incidence of adverse reactions were compared between the two groups. Results The total effective rate of the study group was higher than that of the control group (P<0.05).After treatment,the scores of postprandial fullness,early satiety,abdominal pain or discomfort and upper abdominal burning sensation in both groups were significantly lower than those before treatment, and those of the study group were significantly better than the control group (P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05). Conclusion Flupentixol and melitracen combined with mosapride and pantoprazole in the treatment of FD can improve the patients clinical symptom,with significant effect,and does not increase adverse reactions,whcih is worth clinical  promotion.               KEYWORDS: flupentixol and melitracen; mosapride; pantoprazole; function aldyspepsia

参考文献：
[1] 吕龙 , 黄春 . 氟哌噻吨美利曲辛联合奥美拉唑与莫沙比利治疗功能性消化不良的疗效观察 [J]. 中国医学创新 ,2014,11(17):55-58.
[2] 杨正益 . 泮托拉唑钠肠溶片与莫沙必利治疗功能性消化不良的临床效果及安全性 [J]. 世界华人消化杂志 ,2014,22(29):4514-4518.
[3] 杨云 . 氟哌噻吨美利曲辛联合莫沙比利治疗功能性消化不良临床疗效观察 [J]. 临床合理用药杂志 ,2016,9(19):91-92.
[4] 林国辉 , 叶瑞雄 , 蒋满英 , 等 . 氟哌噻吨美利曲辛联合莫沙必利治疗功能性消化不良临床观察 [J]. 疾病监测与控制 ,2016,10(8):671-673.
[5] 李丽秋 . 泮托拉唑钠肠溶片与莫沙必利治疗功能性消化不良的临床效果观察 [J]. 中国继续医学教育 ,2015,7(8):237-238.
[6] 倪扬 , 任黔玲 . 氟哌噻吨美利曲辛片联合莫沙必利治疗功能性消化不良 87 例 [J]. 中国药业 ,2015,24(13):108-109.
[7] 安菊芬 , 杨国平 . 泮托拉唑联合莫沙必利与单用莫沙必利治疗功能性消化不良的疗效比较 [J]. 海峡药学 ,2012,24(11):220-221.
[8] 李生红 . 泮托拉唑、依托必利联合氟哌噻吨美利曲辛治疗功能性消化不良的临床研究 [J]. 中国处方药 ,2017,15(2):95-96.
[9] 苑淑平 . 泮托拉唑、依托必利联合黛力新治疗功能性消化不良的疗效及安全性 [J]. 河南医学研究 ,2013,22(2):250-251.